Industry News
Sun risk for children of melanoma survivors
Jan 13, 2015
New research has found that the children of melanoma survivors are not receiving optimum sun protection, despite their increased risk of developing melanoma themselves. Read More
Sun risk for children of melanoma survivors
Jan 13, 2015
New research has found that the children of melanoma survivors are not receiving optimum sun protection, despite their increased risk of developing melanoma themselves. Read More
Study finds new treatment target for aggressive blood cancer
Jan 13, 2015
Acute myeloid leukaemia is an aggressive blood cancer with a poor prognosis. Now, fresh clues about a molecular mechanism in the disease may offer a new drug target. Read More
Skin cancer : new mechanism involved in tumour initiation, growth and progression
Jan 13, 2015
Squamous cell carcinoma (SCC) represents the second most frequent skin cancer with more than half million new patients affected every year in the world. Read More
Lung cancer: Phase III data for Gilotrif (afatinib) published in The Lancet Oncology
Jan 13, 2015
Boehringer Ingelheim has announced overall survival (OS) results were published in The Lancet Oncology from two independent Phase III clinical trials (LUX-Lung 3 and LUX-Lung 6) in epidermal growth... Read More
Eating less salt may reduce the risk of stomach cancer: UEG calls for greater salt-awareness across Europe
Jan 13, 2015
Stomach cancer is diagnosed in around 80,000 people in the European Union (EU) each year1 and is associated with a very poor prognosis. Read More
SMC recommends Erbitux for use in the first line treatment of metastatic bowel cancer patients in Scotland
Jan 13, 2015
Erbitux (cetuximab), in combination with FOLFIRI or FOLFOX, has been recommended for use within NHS Scotland by the Scottish Medicines Consortium (SMC) for the first line treatment of metastatic... Read More
Skin cancer : new mechanism involved in tumour initiation, growth and progression
Jan 13, 2015
Squamous cell carcinoma (SCC) represents the second most frequent skin cancer with more than half million new patients affected every year in the world. Read More
Wound-induced skin cancer may be fueled by bacteria
Jan 13, 2015
Researchers at King's College London have identified a new mechanism by which skin damage triggers the formation of tumours, which could have important therapeutic implications for patients suffering... Read More
Favorable OS rates for rectal cancer patients demonstrated by secondary analysis of RTOG 0247
Jan 13, 2015
Locally advanced rectal cancer patients who receive preoperative radiation therapy with either irinotecan plus capecitabine or oxaliplatin plus capecitabine have a four-year overall survival rate of... Read More
Previous Page Next Page